THE ASSOCIATION OF GRAVES' DISEASE WITH MYASTHENIA GRAVIS, WITH A REPORT OF FIVE CASES
Authors: G LEVY, W R MEADOWS, R M GUNNAR
Journal: Annals of Internal Medicine (1951)

Article1 July 1951THE ASSOCIATION OF GRAVES' DISEASE WITH MYASTHENIA GRAVIS, WITH A REPORT OF FIVE CASESGEORGE LEVY, M.D., W. R. MEADOWS, M.D., ROLF M. GUNNAR, M.D.GEORGE LEVY, M.D., W. R. MEADOWS, M.D., ROLF M. GUNNAR, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-35-1-134 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSince the introduction of neostigmine1, 2 as a test for myasthenia gravis, there have been 16 cases3 of myasthenia gravis associated with Graves' disease reported in the literature. In this same period there have been reported a few cases of Graves' disease with muscular weakness which responded to neostigmine but were considered to be thyrotoxic myopathy. However, Brain's classification of muscular disorders associated with Graves' disease4 lends validity to the separation of myasthenia gravis from other types of muscular weakness occurring in association with Graves' disease on the basis of the response to neostigmine.In this paper we present five...Bibliography1. Walker MB: Case showing the effect of prostigmine on myasthenia gravis, Proc. Roy. Soc. Med. 28: 759, 1935. CrossrefMedlineGoogle Scholar2. VietsSchwab HRRS: Prostigmine in diagnosis of myasthenia gravis, New England J. Med. 213: 1280, 1935. CrossrefGoogle Scholar3a. Thorner MW: Relationship of myasthenia gravis to hyperthyroidism, Arch. Int. Med. 64: 330, 1939. b. Thorn, G. W., and Tierney, N. A.: Myasthenia gravis complicated by thyrotoxicosis: creatinine studies, Bull. Johns Hopkins Hosp. 69: 469, 1941. c. Kowalis, G. F., Haines, S. F., and Pemberton, J. DeJ.: Goiter with associated myasthenia gravis, Arch. Int. Med. 69: 41, 1942. d. Carson, J., and Keynes, L. S.: Discussion on myasthenia gravis and thymectomy, Proc. Roy. Soc. Med. 36: 140, 1943. e. Flynn, R.: Graves' disease with disassociation of thyrotoxicosis and ophthalmopathy associated with myasthenia gravis, M. J. Australia 1: 344, 1944. f. Moore, F. D.: Toxic manifestations of thiouracil therapy, J. A. M. A. 130: 315, 1946. g. Cohen, B.: Thyrotoxicosis by myasthenia gravis, South African M. J. 20: 408, 1946. h. Thorn, G. W., and Eder, H. A.: Studies on chronic thyrotoxic myopathy, Am. J. Med. 1: 583, 1946. i. McEachern, D., and Parnell, J. L.: The relationship of hyperthyroidism to myasthenia gravis, J. Clin. Endocrinol. 8: 842, 1948. CrossrefGoogle Scholar4. BrainTurnbull WRHM: Exophthalmic ophthalmoplegia, Quart. J. Med. 21: 293, 1938. Google Scholar5. Tether JE: Intravenous neostigmine in diagnosis of myasthenia gravis, Ann. Int. Med. 29: 1132, 1948. LinkGoogle Scholar6. BennetCash AEPT: Myasthenia gravis; curare sensitivity; new diagnostic test and approach to causation, Arch. Neurol. and Psychiat. 49: 537, 1943. CrossrefGoogle Scholar7. Brain WR: Diseases of the nervous system, 1940, Oxford University Press, London. Google Scholar8. Mattis RD: Ocular manifestations in myasthenia gravis, Arch. Ophth. 26: 969, 1941. CrossrefGoogle Scholar9. Gavey CJ: Ophthalmoplegia as sole manifestation of myasthenia gravis over twenty-five years, Proc. Roy. Soc. Med. 35: 14, 1941. Google Scholar10. Lisman JU: Ocular myasthenia gravis, Am. J. Ophth. 32: 565, 1949. CrossrefMedlineGoogle Scholar11. RundleWilson FFCW: Ophthalmoplegia in Graves' disease, Clin. Sci. 5: 17, 1944. Google Scholar12. Means JH: Hyperophthalmopathic Graves' disease, Ann. Int. Med. 23: 779, 1945. LinkGoogle Scholar13. Laurent LP: Acute thyrotoxic bulbar palsey, Lancet 1: 87, 1944. CrossrefGoogle Scholar14. MorganWilliams HJRH: Muscular atrophy and weakness in thyrotoxicosis, South. M. J. 33: 261, 1940. CrossrefGoogle Scholar15. McEachernRoss DWD: Chronic thyrotoxic myopathy, Brain 65: 181, 1942. CrossrefGoogle Scholar16. KabatJones HCW: Studies in neuromuscular dysfunction: neostigmine, J. Nerv. and Ment. Dis. 103: 107, 1946. CrossrefGoogle Scholar17. Eaton LM: The clinical concept of myasthenia gravis, Proc. Staff Meet., Mayo Clin. 23: 1, 1948. Google Scholar18. TeitelbaumVyner HAHL: Neostigmine methylsulfate therapy in hemiplegia, Arch. Neurol. and Psychiat. 62: 93, 1949. CrossrefMedlineGoogle Scholar19. SchwabChapman RSWP: Clinical uses of neostigmine, M. Clin. North America 31: 1238, 1947. CrossrefMedlineGoogle Scholar20. Eaton LM: Personal communication. Google Scholar21. Goni' AR: Myasthenia gravis, 1946, Williams and Wilkins, Baltimore. Google Scholar22. Eaton LM: Care of the patient who has myasthenia gravis, M. Clin. North America 31: 907, 1947. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Chicago, Illinois*Received for publication March 25, 1950.From the Resident Staff, Department of Medicine, Cook County Hospital, Chicago, Illinois. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByHickam's dictum: Myasthenia Gravis presenting concurrently with Graves' diseaseIntroductionGrave's disease associated with myasthenia gravis: a case reportThe Nature and Significance of the Long-Acting Thyroid StimulatorEndocrine Aspects of Myasthenia GravisAcute Tubular Necrosis Consequent to Encephalomyopathic Thyroid CrisisMYASTHENIA GRAVIS AND HYPERTHYROIDISM: REPORT OF TWO CASES AND REVIEW OF THE LITERATURE*GEORGE D. WEICKHARDT, M.D., F.A.C.P., ARTHUR J. REDMOND, M.D.ASSOCIATION OF MYASTHENIA GRAVIS AND HYPERTHYROIDISM, SHOWING RECIPROCAL RELATIONSHIP: REPORT OF A CASE AND REVIEW OF THE LITERATURE*JACOB JOHN ROBBINS, JOSEPH S. BURKLEMyasthenia gravisThe Diagnosis and Treatment of HyperthyroidismMyasthenia Gravis 1 July 1951Volume 35, Issue 1Page: 134-147KeywordsBrainBrain diseasesElectromyographyHospital medicineMuscular diseasesMuscular weaknessMyasthenia gravis Issue Published: 1 July 1951 PDF DownloadLoading ...